These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33875535)

  • 21. Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.
    Kharbanda EO; Vazquez-Benitez G; Lipkind HS; Klein NP; Cheetham TC; Naleway AL; Lee GM; Hambidge S; Jackson ML; Omer SB; McCarthy N; Nordin JD
    Vaccine; 2016 Feb; 34(7):968-73. PubMed ID: 26765288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal and infant outcomes among women vaccinated against pertussis during pregnancy.
    Berenson AB; Hirth JM; Rahman M; Laz TH; Rupp RE; Sarpong KO
    Hum Vaccin Immunother; 2016 Aug; 12(8):1965-1971. PubMed ID: 27002930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination in the Prevention of Infant Pertussis in the U.S.
    Becker-Dreps S; Butler AM; McGrath LJ; Boggess KA; Weber DJ; Li D; Hudgens MG; Layton JB
    Am J Prev Med; 2018 Aug; 55(2):159-166. PubMed ID: 29910115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.
    Kovac M; Kostanyan L; Mesaros N; Kuriyakose S; Varman M
    Hum Vaccin Immunother; 2018; 14(8):1977-1986. PubMed ID: 29630439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
    Wanlapakorn N; Maertens K; Thongmee T; Srimuan D; Thatsanathorn T; Van Damme P; Leuridan E; Poovorawan Y
    Vaccine; 2020 Oct; 38(44):6914-6921. PubMed ID: 32888740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaiser Permanente Northern California pregnancy database: Description and proof of concept study.
    Zerbo O; Chan B; Goddard K; Lewis N; Bok K; Klein NP; Baxter R
    Vaccine; 2016 Nov; 34(46):5519-5523. PubMed ID: 27727029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infant Hospitalizations and Mortality After Maternal Vaccination.
    Sukumaran L; McCarthy NL; Kharbanda EO; Vazquez-Benitez G; Lipkind HS; Jackson L; Klein NP; Naleway AL; McClure DL; Hechter RC; Kawai AT; Glanz JM; Weintraub ES
    Pediatrics; 2018 Mar; 141(3):. PubMed ID: 29463582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study.
    Walls T; Graham P; Petousis-Harris H; Hill L; Austin N
    BMJ Open; 2016 Jan; 6(1):e009536. PubMed ID: 26739731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficiency of placental transfer of vaccine-elicited antibodies relative to prenatal Tdap vaccination status.
    Post AL; Li SH; Berry M; Itell H; Martinez DR; Xie G; Permar SR; Swamy GK; Fouda GG
    Vaccine; 2020 Jun; 38(31):4869-4876. PubMed ID: 32482459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial.
    Wanlapakorn N; Maertens K; Vongpunsawad S; Puenpa J; Tran TMP; Hens N; Van Damme P; Thiriard A; Raze D; Locht C; Poovorawan Y; Leuridan E
    Clin Infect Dis; 2020 Jun; 71(1):72-80. PubMed ID: 31418814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Prenatal Tetanus, Diphtheria, and Acellular Pertussis Vaccination on Pertussis Severity in Infants.
    Winter K; Cherry JD; Harriman K
    Clin Infect Dis; 2017 Jan; 64(1):9-14. PubMed ID: 27624956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial.
    Perrett KP; Halperin SA; Nolan T; Martínez Pancorbo C; Tapiero B; Martinón-Torres F; Stranak Z; Virta M; Vanderkooi OG; Kosina P; Encinas Pardilla MB; Cristobal García I; Zuccotti GV; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Marcos Fernández M; Rodríguez Zambrano MÁ; Martín García A; Asenjo de la Fuente JE; Camacho Marín MD; de la Calle Fernández-Miranda M; Romero Espinar Y; Marchisio PG; Manzoni P; Mesaros N
    Vaccine; 2020 Feb; 38(8):2095-2104. PubMed ID: 31776029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tdap vaccine attitudes and utilization among pregnant women from a high-risk population.
    Dempsey AF; Brewer SE; Sevick C; Pyrzanowski J; Mazzoni S; O'Leary ST
    Hum Vaccin Immunother; 2016 Apr; 12(4):872-8. PubMed ID: 26430729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women.
    Wanlapakorn N; Maertens K; Chaithongwongwatthana S; Srimuan D; Suratannon N; Vongpunsawad S; Tran TMP; Hens N; Van Damme P; Locht C; Poovorawan Y; Leuridan E
    Vaccine; 2018 Mar; 36(11):1453-1459. PubMed ID: 29426663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study.
    Sancovski M; Mesaros N; Feng Y; Ceregido MA; Luyts D; De Barros E
    Hum Vaccin Immunother; 2019; 15(12):2873-2881. PubMed ID: 31216218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial.
    Perrett KP; Halperin SA; Nolan T; Carmona Martínez A; Martinón-Torres F; García-Sicilia J; Virta M; Vanderkooi OG; Zuccotti GV; Manzoni P; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Stranak Z; Merino Arribas JM; Cilleruelo Ortega MJ; Miranda-Valdivieso M; Arias Novas B; Ramos Amador JT; Omeñaca F; Baca M; Marchisio PG; Mesaros N
    Vaccine; 2020 Feb; 38(8):2105-2114. PubMed ID: 31776027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study.
    Wales DP; Khan S; Suresh D; Ata A; Morris B
    Public Health; 2020 Feb; 179():38-44. PubMed ID: 31726399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.
    Sirivichayakul C; Chanthavanich P; Limkittikul K; Siegrist CA; Wijagkanalan W; Chinwangso P; Petre J; Hong Thai P; Chauhan M; Viviani S
    Hum Vaccin Immunother; 2017 Jan; 13(1):136-143. PubMed ID: 27686283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.